Dr Chia Yin Nin

Dr Chia Yin Nin is a gynaecological oncologist practising in Gleneagles Hospital, Singapore.

Her clinical expertise includes the screening and treatment of gynaecological cancers, such as of the cervix, uterus, ovary, fallopian tubes and vulva, and precancer gynaecological diseases. Other conditions include abnormal pap smears, heavy menses, irregular menses, menstrual cramps, ovarian cysts, uterine prolapse (sagging of the womb) and vagina infections.

Dr Chia performs complex pelvic surgeries, such as open, laparoscopic (keyhole) and robotic surgeries. She performed the first laparoscopic radical hysterectomy in Singapore in 2011.

Dr Chia completed her Bachelor of Medicine, Bachelor of Surgery (MBBS) at the National University of Singapore. She was awarded the Hoops Medal for a distinction in obstetrics and gynaecology and the Singapore Medical Association Bronze medal for excellent academic achievement for her MBBS. In 2008, she obtained her certification in gynaecology oncology from the Royal Australian New Zealand College of Obstetricians and Gynaecologists.

Dr Chia was formerly the deputy head of the Department of Gynaecological Oncology and the head of the gynaecological cancer unit of the Department of Gynaecological Oncology at the Kandang Kerbau Women's and Children's Hospital (KKH).

Dr Chia is the president for the Society of Colposcopy and Cervical Pathology of Singapore and council member of the gynaecology oncology subsection of the College of Obstetrics and Gynaecology in Singapore. She is one of the founding members and council members of the Asian Society of Gynaecologic Oncology. Dr Chia also sits on the editorial board for the Journal of Gynaecologic Oncology.

Aside from clinical work, Dr Chia was an adjunct assistant professor at the Duke-NUS Medical School, Singapore where she received numerous teaching awards for her exemplary teaching.

Dr Chia's research interests include gynaecological cancer and human papillomavirus (HPV) vaccines, and has participated in related landmark clinical trials. For instance, she was the principal investigator for the multicentre Bayer ovarian cancer 12007 study.